There are 2934 resources available
The optimal sequence: Does overall survival matter?
Presenter: Tony S.K. Mok
Session: The next horizon in metastatic non-small cell targeted therapy
Resources:
Slides
Webcast
Targeted KRAS mutation
Presenter: Pasi Jänne
Session: The next horizon in metastatic non-small cell targeted therapy
Resources:
Slides
Webcast
Uncommon targets: BRAF, MET and NTRK
Presenter: David Planchard
Session: The next horizon in metastatic non-small cell targeted therapy
Resources:
Slides
Webcast
From tumour antigens to HLA peptides in melanoma
Presenter: Yardena Samuels
Session: Tumour neoantigens
Resources:
Slides
Liquid biopsies to predict response or resistance in IO
Presenter: Dominic Rothwell
Session: Which are the preferred platforms for IO biomarkers discovery?
Resources:
Slides
Webcast
Conclusions and perspectives
Presenter: John Haanen
Session: Which are the preferred platforms for IO biomarkers discovery?
Resources:
Slides
Webcast
Umbrella trials
Presenter: Tim Maughan
Session: How to use the available results of precision medicine clinical trials
Resources:
Slides
Webcast
Other platform trials of precision medicine
Presenter: Christophe Le Tourneau
Session: How to use the available results of precision medicine clinical trials
Resources:
Slides
Webcast
Precision medicine: Counterpoint
Presenter: Emiliano Calvo
Session: How to use the available results of precision medicine clinical trials
Resources:
Slides
Webcast
Conclusions and perspectives
Presenter: Christian Dittrich
Session: How to use the available results of precision medicine clinical trials
Resources:
Slides
Webcast